-
Alzheimer’s Drug Aricept Linked To Rhabdomyolysis, A Potentially Serious Muscle Condition
Is Rhabdomyolysis A Side Effect For Aricept, Only, Or For Other Cholinesterase Inhibitors, Also? (Posted by Tom Lamb at DrugInjuryWatch.com) Back in January 2015 Health Canada issued a postmarket surveillance warning about…
-
Pancreatic Cancer Associated With Use Of Diabetes Medicines In DPP-4 Inhibitor Drug Class
Increased Risk For Patients With Newly Diagnosed Type 2 Diabetes According To Recent Medical Research Study (Posted by Tom Lamb at DrugInjuryWatch.com) Use of dipeptidyl peptidase-4 inhibitors (DPP-4i) diabetes medicines is associated…
-
Fournier’s Gangrene Is A Side Effect Of Farxiga, Invokana, Jardiance, And Other SGLT2 Inhibitor Diabetes Drugs — Or Is It?
At The Recent American Diabetes Association (ADA) Scientific Sessions There Was An Expression Of Doubt About Warnings For This Association (Posted by Tom Lamb at DrugInjuryWatch.com) In August 2018 the FDA required…
-
Xeljanz Warning For Increased Risk Of Blood Clots And Death With Higher Dose Used For Ulcerative Colitis
"Black Box Warning" For Xeljanz 10 mg Twice Daily Dose Required By FDA In July 2019 Follows Regulatory Action In Europe (Posted by Tom Lamb at DrugInjuryWatch.com) A Xeljanz FDA Drug Safety…
-
Uloric Use By Patients With Major Cardiovascular Disease Associated With Higher Risk Of Deaths
New Drug Safety Warning: Uloric Should Be Avoided When There Is Prior Myocardial Infarction, Stroke, Or Unstable Angina (Posted by Tom Lamb at DrugInjuryWatch.com) From this Drug Safety Update issued July 17,…
-
Lemtrada: Reports Of Serious Cardiovascular Events And Immune-Mediated Reactions Under Investigation
UK Drug Safety Regulator MHRA Imposes Lemtrada Use Restrictions And Mandates Patient Monitoring For Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2019 the UK's Medicines and Healthcare products Regulatory…